News
最新消息
|
|
|
ACTION for ACTS ! （Asian Clinical Trials and Solutions）
This year is the 20th anniversary for ASKLEP. We will take "ACTION for ACTS (Asian Clinical Trials and Solutions)" as the new vision for company and "Newborn ASKLEP" will be our identity toward this anniversary. Moreover, decision of the brand-new international strategy will be made.
ASKLEP held the 5th「ASKLEP Annual Global Conference」targeting to the pharmaceutical industry. In recent years, the development of the anti-tumor agents in Japan grows very fast. In order to make sure the therapeutic target for future drug development, we have invited first-line clinical trial execution person throughout Asia as our guest speaker to share the speak titled 「Current and Future Contribution of Asian countries for Global Cancer Drug Development」 for providing the updated information about the development of anti-tumor agents in Asian countries.
|
|
|
